Clinical Trials
24 trialsDental Cleaning to Prevent Chronic Graft-Versus-Host Disease
Fred Hutchinson Cancer Center
Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Mayo Clinic
STIM 2
University Hospital, Bordeaux
Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto
Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD
University of Seville
SIMPly-CARE
Rigshospitalet, Denmark
Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome
First Affiliated Hospital of Zhejiang University
PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT
Shanghai Jiao Tong University School of Medicine
Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy
University of Milano Bicocca
Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia
Fundación Teófilo Hernando, Spain
ProT4
University College, London
Betadine Pleurodesis Via Tunneled Pleural Catheters
Yale University
Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)
M.D. Anderson Cancer Center
WIN
University Hospital Southampton NHS Foundation Trust
AmbOx
Royal Brompton & Harefield NHS Foundation Trust
SPIRIT2
Newcastle University
Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG
M.D. Anderson Cancer Center
Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
University of California, San Diego
Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
University of Pittsburgh
ZicBol
University Hospital, Linkoeping
Rituximab for Prevention of Chronic GVHD
Dana-Farber Cancer Institute
Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance
Hospital Universitario Dr. Jose E. Gonzalez
STIM
University Hospital, Bordeaux
Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children
Ann & Robert H Lurie Children's Hospital of Chicago